clarithromycin has been researched along with Orthomyxoviridae Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arikata, M; Ishigaki, H; Itoh, Y; Kawaoka, Y; Kinoshita, T; Le, MQ; Nakayama, M; Ogasawara, K; Shichinohe, S; Shimizu, T | 1 |
| Indalao, IL; Kido, H; Kim, H; Kimoto, T; Mizuno, K; Sakai, S; Sawabuchi, T; Takahashi, E | 1 |
| Asakura, T; Asami, T; Atarashi, K; Betsuyaku, T; Fujii, H; Hasegawa, N; Hegab, AE; Honda, K; Ishii, M; Iwata, S; Kamata, H; Kanai, T; Koyasu, S; Nakamoto, N; Namkoong, H; Suzuki, S; Tasaka, S; Yagi, K | 1 |
| Hara, A; Harada, T; Ishimatsu, Y; Izumikawa, K; Kakugawa, T; Kohno, S; Kosai, K; Morita, T; Mukae, H; Nakashima, S; Sakamoto, N; Yanagihara, K | 1 |
| Chida, J; Fujihashi, K; Fujii, K; Indalao, IL; Kataoka, K; Kido, H; Konoha, K; Mizuno, D; Takahashi, E | 1 |
| Shiroki, K | 1 |
| Fukuda, Y; Imakita, M; Kurokawa, M; Shiraki, K; Tsurita, M; Watanabe, Y | 1 |
7 other study(ies) available for clarithromycin and Orthomyxoviridae Infections
| Article | Year |
|---|---|
Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys.
Topics: Animals; Antiviral Agents; Clarithromycin; Cytokines; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H7N9 Subtype; Lung; Macaca fascicularis; Orthomyxoviridae Infections; Viral Load | 2019 |
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Chemokine CCL2; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Female; Influenza A virus; Lung; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Myocardium; Orthomyxoviridae Infections | 2018 |
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
Topics: Animals; Anti-Bacterial Agents; CD11b Antigen; Cell Differentiation; Cell Proliferation; Clarithromycin; Gastrointestinal Hormones; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myeloid Cells; Neuropeptides; Orthomyxoviridae; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Pneumococcal; Shock, Septic; STAT3 Transcription Factor; Streptococcus pneumoniae | 2018 |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Topics: Animals; Bacterial Load; Cell Count; Chemokines; Clarithromycin; Coinfection; Disease Models, Animal; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Pneumonia, Bacterial; Pulmonary Emphysema; Streptococcus pneumoniae; Survival Analysis; Viral Load | 2016 |
Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza
Topics: Administration, Oral; Animals; Antibodies, Neutralizing; Antiviral Agents; B-Cell Activating Factor; Bronchi; Clarithromycin; Cytidine Deaminase; Dendritic Cells; Female; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin Class Switching; Influenza A Virus, H1N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Spleen; Tumor Necrosis Factor-alpha | 2012 |
[Anti-influenza mechanism of macrolide antibiotics inducing airway IL-12 production in murine influenza model ].
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Models, Animal; Female; Interferon-gamma; Interleukin-12; Mice; Mice, Inbred DBA; Orthomyxoviridae Infections | 2003 |
Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.
Topics: Administration, Intranasal; Administration, Oral; Animals; Anti-Bacterial Agents; Body Weight; Clarithromycin; Dogs; Female; Interleukin-12; Mice; Mice, Inbred DBA; Orthomyxoviridae; Orthomyxoviridae Infections; Recombinant Proteins; Survival Rate | 2001 |